Is Kindred Biosciences (KIN) Ready To Hit $10 Mark?

Investors who are on the hunt for penny stocks have a lot of options in the market but one of the penny stocks that made a strong move on Thursday was that of Kindred Biosciences Inc (NASDAQ: KIN).

The stock gained strong momentum in recent days and on Thursday; it rallied by 9%. In light of such a move, it could be a good idea to take a closer look at the company’s business.

The company is a biopharmaceutical based in the veterinary sector. It is involved in the development of products that are meant to enhance the lives of working animals as well as pets.

The most important product that is under development at Kindred at this point is KIND-030. The product is meant for tackling the menace caused by Parvovirus. In this regard, it is also important for investors to note that in December 2020, the company also signed a deal with Elanco Animal Health for producing KIND-030.

Related:  AgraFlora Organics International (AGRA.CN) Has A New Finance Director With Over 14 Years Experiences

Uson Abdilazhanov

Editor and Computer ExpertA hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/zjrlrgmy/public_html/wp-includes/functions.php on line 5107